Regulatory Press Releases

Revenues increased in the fourth quarter by four percent to 61.8 (59.6) and EBIT increased by 60 percent to 8.8 MSEK (5.5). Profitability was positively affected by currency effects. For the full year 2022, sales grew by 76 percent, out of which 16 percent in organic growth. Operating profit increased to 32.4 MSEK (20.1). In the fourth quarter, business unit Surgical Table sales declined by four percent...

Stille AB reports that Torbjörn Sköld, incoming CEO starting March 20th, 2023, purchased 8,770 shares in Stille on January 31st, 2023. The shares were purchased at 114 SEK per share, with a total value of 997,780 SEK. Torshälla, February 2nd, 2023. For more information, please contact: Niklas Carlén Interim CEO and President +46 (0)73 087 49 70 | niklas.carlen@stille.se Stille...

Torbjörn Sköld will begin his tenure as new Stille’s new CEO on March 20th, 2023, where he will replace Hanna Ernestam Wilkman who has been the company’s CEO since April 1st, 2019. Stille’s board of directors have decided to appoint Niklas Carlén as Interim CEO up until Torbjörn will commence his employment. Niklas has been the company’s CFO since June...

Torbjörn will begin his tenure on March 20th, 2023, where he will replace Hanna Ernestam Wilkman who has been the company’s CEO since April 1st, 2019. Torbjörn comes most recently from De Puy Synthes EMEA, a Johnson & Johnson company, where he has been Vice President. Lars Kvarnhem, chairman of the board comments today’s announcement: “First, I would like to thank Hanna...

Revenues increased by 17 percent to 59.6 MSEK (51.1). Operating profit increased by 32 percent to 7.2 MSEK (5.5). Positive currency effects of 2.7 MSEK affected the result after financial items. Revenues for Surgical Instruments increased by six percent to 30.1 MSEK (28.4). Profitability was affected by an unfavorable product and geographic market mix. Surgical Table-revenues grew by 30 percent to...